How does external reference pricing work in developing countries: evidence from Iran
Introduction: Governments apply different pricing policies to ensure public accessibility, availability, and affordability of medicines. In this way, external reference pricing (ERP) because of its easy implementation is used widely across countries. However, ERP is completely path dependent, and it...
Saved in:
Main Authors: | Fatemeh Babaie (Author), Mohammad Hossein Motevalli (Author), Gholamhossein Mehralian (Author), Farzad Peiravian (Author), Nazila Yousefi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Parental self-medication with antibiotics in Iran
by: Farahnaz Zeinali, et al.
Published: (2018) -
Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment
by: Gita Afsharmanesh, et al.
Published: (2021) -
An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country
by: Asiye Moosivand, et al.
Published: (2021) -
Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries
by: Azin Kadkhodamanesh, et al.
Published: (2021) -
The 2nd Euro-Asian Congress of Pharmacoepidemiology: Non-Communicable Diseases as a Threat to Sustainable Development
by: Nazila Yousefi, et al.
Published: (2023)